• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性胰腺炎中的血清载脂蛋白A2亚型

Serum apolipoprotein A2 isoforms in autoimmune pancreatitis.

作者信息

Kobayashi Takashi, Sato Yu, Nishiumi Shin, Yagi Yosuke, Sakai Arata, Shiomi Hideyuki, Masuda Atsuhiro, Okaya Shinobu, Kutsumi Hiromu, Yoshida Masaru, Honda Kazufumi

机构信息

Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan.

Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan.

出版信息

Biochem Biophys Res Commun. 2018 Mar 11;497(3):903-907. doi: 10.1016/j.bbrc.2018.02.170. Epub 2018 Feb 23.

DOI:10.1016/j.bbrc.2018.02.170
PMID:29481802
Abstract

Recently, apolipoprotein A2 (apoA2) isoforms have been reported as candidate serum/plasma biomarkers of pancreatic cancer. However, the distribution of apoA2 isoforms in patients with autoimmune pancreatitis (AIP) has not been investigated yet. In this study, we evaluated the distribution of serum apoA2 isoforms; i.e., homodimer apoA2-ATQ/ATQ, heterodimer apoA2-ATQ/AT, and homodimer apoA2-AT/AT, in AIP patients and healthy volunteers (HV) using enzyme-linked immunosorbent assays, and the clinical characteristics and serum levels of each apoA2 isoform in 32 AIP patients and 38 HV were investigated. The calculated apoA2-ATQ/AT levels of the AIP patients were significantly lower than those of the HV, which agreed with results obtained for patients with pancreatic cancer. Interestingly, most of the AIP patients exhibited high levels of apoA2-ATQ along with low levels of apoA2-AT, indicating that the processing of the C-terminal regions of apoA2 dimer was inhibited in the AIP patients. This specific distribution of serum apoA2 isoforms might provide important information about the disease states of AIP patients and aid the differential diagnosis of AIP versus pancreatic cancer.

摘要

最近,载脂蛋白A2(apoA2)亚型已被报道为胰腺癌的候选血清/血浆生物标志物。然而,apoA2亚型在自身免疫性胰腺炎(AIP)患者中的分布尚未得到研究。在本研究中,我们使用酶联免疫吸附测定法评估了AIP患者和健康志愿者(HV)血清中apoA2亚型的分布,即同型二聚体apoA2 - ATQ/ATQ、异型二聚体apoA2 - ATQ/AT和同型二聚体apoA2 - AT/AT,并对32例AIP患者和38例HV的每种apoA2亚型的临床特征和血清水平进行了研究。AIP患者计算得出的apoA2 - ATQ/AT水平显著低于HV,这与胰腺癌患者的结果一致。有趣的是,大多数AIP患者表现出高水平的apoA2 - ATQ和低水平的apoA2 - AT,这表明apoA2二聚体C末端区域的加工在AIP患者中受到抑制。血清apoA2亚型的这种特定分布可能为AIP患者的疾病状态提供重要信息,并有助于AIP与胰腺癌的鉴别诊断。

相似文献

1
Serum apolipoprotein A2 isoforms in autoimmune pancreatitis.自身免疫性胰腺炎中的血清载脂蛋白A2亚型
Biochem Biophys Res Commun. 2018 Mar 11;497(3):903-907. doi: 10.1016/j.bbrc.2018.02.170. Epub 2018 Feb 23.
2
CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation.CA19-9 和载脂蛋白 A2 异构体作为胰腺癌的检测标志物:一项前瞻性评估。
Int J Cancer. 2019 Apr 15;144(8):1877-1887. doi: 10.1002/ijc.31900. Epub 2018 Dec 4.
3
Apolipoprotein A2 isoforms associated with exocrine pancreatic insufficiency in early chronic pancreatitis.载脂蛋白 A2 异构体与早期慢性胰腺炎外分泌胰腺功能不全相关。
J Gastroenterol Hepatol. 2023 Nov;38(11):1949-1957. doi: 10.1111/jgh.16302. Epub 2023 Jul 27.
4
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.利用载脂蛋白 A2 异构体开发用于早期检测胰腺癌的血液生物标志物的临床研究。
J Gastroenterol. 2024 Mar;59(3):263-278. doi: 10.1007/s00535-023-02072-w. Epub 2024 Jan 23.
5
Apolipoprotein A2 Isoforms in Relation to the Risk of Myocardial Infarction: A Nested Case-Control Analysis in the JPHC Study.载脂蛋白 A2 异构体与心肌梗死风险的关系:JPHC 研究中的巢式病例对照分析。
J Atheroscler Thromb. 2021 May 1;28(5):483-490. doi: 10.5551/jat.56218. Epub 2020 Aug 29.
6
Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.血浆载脂蛋白AII亚型作为接受放化疗的胰腺腺癌患者胰腺外分泌紊乱标志物的临床意义,关注胰腺形态学变化
Biomed Res Int. 2019 Apr 4;2019:5738614. doi: 10.1155/2019/5738614. eCollection 2019.
7
Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer.使用血浆载脂蛋白A2亚型筛查胰腺癌高危状态的前瞻性研究。
Cancers (Basel). 2020 Sep 14;12(9):2625. doi: 10.3390/cancers12092625.
8
Potential of Carbohydrate Antigen 19-9 and Serum Apolipoprotein A2-Isoforms in the Diagnosis of Stage 0 and IA Pancreatic Cancer.碳水化合物抗原19-9和血清载脂蛋白A2异构体在0期和IA期胰腺癌诊断中的潜力
Diagnostics (Basel). 2024 Aug 30;14(17):1920. doi: 10.3390/diagnostics14171920.
9
Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.通过分析血清明胶酶水平鉴别自身免疫性胰腺炎与胰腺癌
Pancreas. 2016 Aug;45(7):1048-55. doi: 10.1097/MPA.0000000000000576.
10
Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms.通过载脂蛋白 A2 异构体的血液检测进行胰腺癌风险分层。
Cancer Biomark. 2022;33(4):503-512. doi: 10.3233/CBM-210198.

引用本文的文献

1
Risk Stratification for Malignant Potential of Intraductal Papillary Mucinous Neoplasms Using the Apolipoprotein-A2 Isoforms Blood Test.使用载脂蛋白A2亚型血液检测对导管内乳头状黏液性肿瘤的恶性潜能进行风险分层。
Clin Transl Gastroenterol. 2025 May 12;16(6):e00856. doi: 10.14309/ctg.0000000000000856. eCollection 2025 Jun 1.
2
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.利用载脂蛋白 A2 异构体开发用于早期检测胰腺癌的血液生物标志物的临床研究。
J Gastroenterol. 2024 Mar;59(3):263-278. doi: 10.1007/s00535-023-02072-w. Epub 2024 Jan 23.
3
EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma.
EphA2 蛋白水解片段作为早期胰腺导管腺癌的敏感诊断生物标志物。
Cancer Res Commun. 2023 Sep 15;3(9):1862-1874. doi: 10.1158/2767-9764.CRC-23-0087.
4
Apolipoprotein A-II, a Player in Multiple Processes and Diseases.载脂蛋白A-II,多种生理过程和疾病中的参与者。
Biomedicines. 2022 Jul 2;10(7):1578. doi: 10.3390/biomedicines10071578.
5
The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review.可溶性血清生物标志物在自身免疫性胰腺炎中的临床应用:一项系统综述。
Biomedicines. 2022 Jun 26;10(7):1511. doi: 10.3390/biomedicines10071511.
6
Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms.通过载脂蛋白 A2 异构体的血液检测进行胰腺癌风险分层。
Cancer Biomark. 2022;33(4):503-512. doi: 10.3233/CBM-210198.
7
Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer.使用血浆载脂蛋白A2亚型筛查胰腺癌高危状态的前瞻性研究。
Cancers (Basel). 2020 Sep 14;12(9):2625. doi: 10.3390/cancers12092625.
8
Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer.生物标志物和成像技术在胰腺癌早期检测中的应用。
Cancers (Basel). 2020 Jul 19;12(7):1965. doi: 10.3390/cancers12071965.